Status and phase
Conditions
Treatments
About
Investigator-initiated, international, multicentre, randomized, open-label, (neo)adjuvant phase III study in target population (stage III, HER2-negative, BRCA1-like breast cancer patients) comparing optimized standard-dose chemotherapy with intensified, alkylating chemotherapy with stem cell rescue.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
174 participants in 2 patient groups
Loading...
Central trial contact
Sabine Linn, Prof. MD; Vincent de Jong, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal